Givaudan is continuing on its path to diversify from fragrance to include more science based active cosmetics, recently acquiring 100% of the shares of Induchem Holding AG and its subsidiaries. According to Givaudan, Induchem’s portfolio of products is based on a wide range of innovative and highly functional active ingredients with proven efficacy results, as well as research expertise in fields such as biocatalysis, metagenomics, and biochemical synthesis. Induchem primarily operates from Volketswil, Switzerland, Toulouse, France and New York, USA, and employs 65 people.
 
Gilles Andrier, CEO of Givaudan, said: “Induchem is a second key step, after the acquisition of Soliance, towards our ambition to make Givaudan a significant player in the Active Cosmetic Business. Induchem brings strong complementary capabilities to Givaudan and will greatly contribute in achieving our 2020 ambition to become a key player in this fast growing business. We are delighted to welcome Induchem’s employees to Givaudan; our high cultural fit will contribute greatly to a successful integration.”
 
Maurizio Volpi, president of Givaudan’s Fragrance Division said: “We expect Induchem to become an integral part of the Active Cosmetic Ingredients (ACI) business within the Fragrance Division. We expect to integrate Givaudan ACI and Induchem, hence expanding our portfolio of products and creating a strong R&D and marketing platform to drive future growth in this space. Induchem has a strong track record in innovation, which can bring value to our customers and to their consumers. Induchem has developed a very strong brand, an innovative portfolio of products, and very strong talent that we will continue to develop with the Induchem team for a successful future together”.
 
Terms of the deal have not yet been disclosed.